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ABSTRACT 
 
BACKROUND  
 Diabetes mellitus (DM) is an important public health problem in developing 
countries. Drug utilization study of anti-diabetic agents is of paramount importance to 
promote rational drug use in diabetics and make available valuable information for the 
healthcare team. The aim of study was to investigate the drug utilization pattern in type-2 
diabetic patients. 
 
PATIENT AND METHODS 
 A prospective, cross-sectional study was carried out in medicine outpatient at 
government hospital, tirupur for a period of six weeks. Patients who fulfilled inclusion 
criteria and had type-2 diabetes mellitus were included in the study. Data was analysed 
using Excel 2007 
 
RESULT 
 A total 110 patients were enrolled in the study. In this study, type-2 diabetes was 
more prevalent in elder patient of age group 61-70 years[41(37.275%)]. Male patients 
were [52(47.24%)] while female patient were [58(52.73%)]. Most of the common utilized 
class of drugs was Biguanides 70% followed by Sulphonylureas 58.18%. 
 
CONCLUSION 
 Metformin was the most utilized (70%) anti-diabetic agent for type-2 diabetes. 
The principal aim of this study is to facilitate the rational use of drugs in population.  
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INTRODUCTION 
Diabetes mellitus is a national as well as global epidemic disease in terms of 
incidence, healthcare costs and overall complications as reported by the center for disease 
control (CDC)¹ . Diabetes affects some 300 million people world-wide, and is on the 
increase. Chronic exposure to high blood glucose is a leading cause of renal failure, 
visual loss and a range of other types of tissue damage. Diabetes also predisposes to 
arterial disease, not least because it is often accompanied by hypertension, lipid disorders 
and obesity² Nearly 18.2 million Americans have Diabetes, yet only about two thirds of 
them have been diagnosed. The economic burden of DM approximated 132 million 
dollars in 2002, including direct medical and treatment costs as well as indirect costs 
attributed to disability and mortality3. It has estimated that the total number of people 
with diabetes in 2010 to around 50.8 million in India, rising to 87 million by 2030³. 
 
DEFINITION 
 Diabetes mellitus is a heterogeneous group of diseases characterized by chronic 
elevation of glucose in the blood. It arises because the body is unable to produce enough 
insulin for its own needs, either because of impaired insulin secretion, impaired insulin 
action, or both4. 
ROLE OF INSULIN AND GLUCOGON 
Two hormones which responsible for the maintaining the balance of blood glucose 
is insulin and glucagon, which produced in the islets of pancreas5. Insulin is a hormone 
that is secreted by beta cells in the pancreas and facilitates storage of glucose as glycogen 
free fatty acid as triglycerides, amino acid as protein. It also inhibits the breakdown, of fat 
and protein and production of glucose and ketone by the liver. Glucagon on the other 
hand is secreted by alpha cells of pancreas islets and stimulate mobilization of glucose, 
free fatty acids as glycerol as well as stimulating hepatic uptake of amino acid and the 
conversion of their carbon skeletons to glucose. 
INTRODUCTION 
_____________________________________________________________________________ 
 
__________________________________________________________________        
The Erode college of Pharmacy                                                                  2 
 
 
This hormone also stimuli the production of ketone from free fatty acid. Glucose is 
the key regulator of insulin secretion although amino acids, ketones certain nutrients, 
gastro intestinal peptidase and neurotransmitters also influence insulin secretion. Meals 
or other major stimuli induce bursts insulin secretion that may last for 3-4 hours before 
returning to baseline. After meal plasma insulin rises sharply and glucagon level declaim 
there for the ratio of insulin to glucagon rises, as a result 
 Dietary carbohydrate is stored in muscle and liver as glycogen. 
 Free fatty acids stored as triglycerides in fat tissue. 
 Protein metabolism shifts in the direction of protein synthesis 
 
When all the nutrients have been assimilated and plasma glucose returns to it basal 
premeallevel, plasma insulin level declaim, glucagon level rise, and the insulin/glucagon 
ratio returns to pre meal level. These prevent excessive insulin action that might lower 
the blood glucose enough to cause hypoglycemia. Thus, an immediate rise, an early peak, 
and prompt fall in insulin secretion are characteristic of normal metabolism around the 
time of meal. Abnormalities in these patterns of insulin and glucagon secretions are early 
signs of islet dysfunction in diabetes mellitus6. 
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There are four cell types with the islets of Langerhans. 
1. Insulin secreting beta cells, which are a key component of islets of Langerhans, 
are located in the center portion of the islets are the predominant type (80% of the 
cells). 
2.  Glucagon secreting alpha cells (about 20% of the islet cells) are located mainly in 
the periphery. 
3. The beta cells, which secrete somatostatins are located between these two cell 
types and are few in number. 
4. Pancreatic polypeptide-secreting pp cells(also called F cells) are located mainly 
the islets in the posterior lobe of pancreas. 
 
Pancreatic islet function is abnormal in type 2 diabetes mellitus, the response to 
glucose by insulin and glucagon is inappropriate. The defect is evident early in the 
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development of the disease and can be observed in persons with pre diabetics. This 
believed to be due to abnormal islet function involving both alpha cells and beta cells7. 
 
DIABETES AND ISLETS DYSFUNCTION 
  Type 2 diabetes characterized mainly by three   pathophysiologic   
abnormalities. 
  Peripheral insulin resistance 
 
 Impaired insulin secretion 
 
 Excessive hepatic glucose production8 
 
As the disease progress, high levels of glucagon coupled with low levels of insulin 
drive excessive hepatic glucose production and the emergence of hyperglycemia.  
Pancreatic islets function is abnormal in type 2 diabetes9. It’s found that United Kingdom 
prospective diabetes (UKPD) study indicated that by the time type 2 diabetes diagnosed, 
individual have already lost up to 50% of their beta cell function. Decline proceeds rate 
6% per year9. 
 
TYPES OF DIABETES MELLITUS 
 Out of many types of diabetes, the most common once are 
I. Type 1 diabetes mellitus 
 
 Immune mediated 
 Idiopathic 
  
II. TYPE 2 diabetes mellitus 
 
III. Other specific type of diabetes 
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 Genetic defect of islet beta cell function 
 Genetic defect of insulin action 
 Disease of the exocrine pancreas 
 Endocrinopathies 
 
 Drug or chemical induced diabetes 
 Infections 
 Other genetic symptoms10 
 
IV. Diabetes during pregnancy 
 
TYPE 1 DM (IDDM) 
   
  Which occur due to either autoimmune T cell mediated B cell 
destruction or idiopathic reason, which leads to absolute deficiency of insulin. 
This is account for 10% of all diabetes cases and usually occurs in young age 
(below 30 years). Type 1 DM is characterized be faster onset of symptoms11 
 
TYPE 2 DM (NIDDM) 
 
  About 90% of total diabetes cases are type 2 DM and which more 
common above the age of 40. It is caused by deficient action of insulin due to 
decreased production, decreased insulin sensitivity to cells or both. The symptoms 
of type 2 DM are occur slowly in onset12. 
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DIABETES DURING PREGNANCY 
It is a form of glucose intolerance occurs during pregnancy. It is detected at 
24 to 28 weeks of gestation and requires insulin injections. 
The patients who are at increased risk of GDM belong to the following 
categories  
 >25 years of age 
 Over Weight 
 First degree family history of diabetes 
 Previous history of abnormal glucose metabolism 
 Glycosuria 
 Previous poor obstetric history  
 Ethnicity associated with high prevalence of diabetes mellitus  
 A previous large baby weighing more than 4 kg (91 bs) 
       Both the woman and the child pose a high risk due to gestational diabetes13. 
 
OTHER SPECIFIC TYPES 
   Genetic defects of b-cell function, Genetic defects in insulin     action, 
Diseases of the pancreas, Endocrinopathies, Drug- or chemical-induced, Infections14. 
 
EPIDEMIOLOGY 
TYPE 1 DM (IDDM) 
   Type 1 diabetes is caused by an absolute deficiency of insulin. This 
is account for 10% of all diabetes cases and usually occurs in young age (below 30 
years). Type 1 DM is characterized by faster onset of symptoms. Affecting approximately 
20 million people worldwide (American Diabetes Associated, 2001). Although type 1 
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Diabetes affects all age groups, the majority of individuals are diagnosed either at around 
the age of 4-5 years. 
 
TYPE 2 DM (NIDDM) 
 About 90% of total diabetes cases are type 2 DM and which more common above 
the age of 40. It is caused by deficient action of insulin due to decreased production, 
decreased insulin sensitivity to cells or both. 
 The symptoms of type 2 DM are occur slowly in onset. There are approximately 
1.4 million people with diagnosed type 2 diabetes in the UK, with a further 1 million 
having undiagnosed type 2 diabetes15. 
 
ETIOLOGY 
 
TYPE ONE DIABETES (10-15%) 
 Type 1 diabetes mellitus comprises several diseases of   the pancreatic beta cells 
which leads to an absolute insulin deficiency16. 
 
TYPE TWO DIABETES (85-90%) 
 Insulin resistance (overweight people), Inadequate insulin production (learn 
people), or combination of both17. 
 
DIABETES DURING PREGNANCY 
 Diabetes diagnosed during pregnancy, increased health risk to mother and baby, 
may require insulin injection, goes away after birth but increased risk of developing type 
2DM for mother and child18. 
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CLINICAL MANIFESTATIONS 
Signs and symptoms 
 Diabetes symptoms very depending on how much your blood sugar is elevated. 
Some people,especially those with prediabetes or type 2 diabetes, may experience 
symptoms initially. Intype1 diabetes,symptoms tend to come on quickly 
and be more severe. Some of the signs and symptoms of type 1 and type 2 diabetes 
include 
 
 Weakness 
 Increased thirst 
 Frequent urination 
 Extreme hunger 
 Unexplained weight loss 
 Presence of ketones in the urine (ketones are a byproduct of the breakdown of 
muscle and fat that happens when there’s not enough insulin) 
 Fatigue 
 Blurred vision 
 Slow-healing sores 
 High blood pressure 
           Frequent infections, Such as gums or skin inflections and vaginal or bladder 
Infections19 
 
PATHOPHYSIOLOGY 
 Insulin is produced in the pancreatic B cells, initially as a polypeptide precursor 
(preproinsulin), then it converts to proinsulin and it converts to insulin by removal of 4 
amino acids. Insulin secretion is stimulate4d by the glucose in the body, the response is 
started by the intake of nutrients and the release if gastro intestinal peptide hormones. 
INTRODUCTION 
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After released from pancreas insulin is entered in to portal circulation, insulin is 
metabolized by liver and kidney. 
In type I diabetes mellitus is an deficiency if insulin that leads to hepatic glucose 
output by uncontrolled hepatic glucogenolysis and gluconeogenesis, and glucose uptake 
is decreased in tissues which lead to hyperglycemia.  
In type 2 diabetes mellitus insulin secretion reduced over a period of time and 
glucose level is maintained for a period of time by hyperinsulinaemia and but the B cell 
function is detoriate finally and leads to hyperglycemia. At the time of diagnose most of 
the patients may have lost 50% of the B cell function continue to detoriate with time, 
often leading to the need of insulin therapy. 
 Insulin resistance in cells are increased when the abdominal fats are increased , 
abdominal fat resistant to the antilipolytic effect of insulin, leads to more free fatty acid 
release, which cause for insulin resistance in the liver and muscle. The increased glucose 
production in liver and inhibition of insulin mediated glucose uptake in the muscle result 
in increased level of glucose in body20 . 
 
COMPLICATION  
 Long –term complications of diabetes develop gradually. The longer you have 
diabetes and the less controlled your blood sugar the higher the risk of complications. 
Eventually, diabetes complications may be disabling or even life – threatening. Possible 
complications include21. 
 
Acute Problems: 
1. Diabetic ketoacidosis 
2. Hypoglycemia  
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Chronic complications: 
1. Micro vascular complications  
Diabetic retinopathy 
Diabetic neuropathy 
Diabetic nephropathy 
Diabetic foot  
 
2. Macro vascular complications 
Peripheral vascular disease, coronary artery disease  
Myocardial infarction 
Hypertension and cerebrovascular diseases22. 
MICRO VASCULAR COMPLICATION 
 There are three main micro vascular complications of diabetes 
 Diabetic retinopathy  
 Diabetic neuropathy 
 Diabetic nephropathy 
 
DIABETIC RETINOPATHY 
 Diabetes can damage the blood vessels of the retina (diabetic retinopathy), 
potentially leading to blindness. Diabetes also increases the risk of other serious vision 
conditions, such as cataracts and glaucoma. 
 
DIABETIC NEUROPATHY 
 Abnormal and decreased sensation, usually in a ‘glove and stocking’ distribution 
starting with the feet but potentially in other nerves, later often fingers and hands. When 
combined with the damaged blood vessels this can lead to diabetic foot. Other form of 
INTRODUCTION 
_____________________________________________________________________________ 
 
__________________________________________________________________        
The Erode college of Pharmacy                                                                  11 
 
diabetic neuropathy may present as mononeuritis or autonomic neuropathy. Diabetic 
amyotrophy is muscle weakness due to neuropathy. 
 
DIABETIC NEPHEROPATHY  
 Damage to the kidney which can lead to chronic renal failure, eventually requiring 
dialysis. Diabetes mellitus is the most common cause of adult kidney failure worldwide 
in the developed world23. 
 
MACROVASCULAR COMPLICATION 
 Macro vascular complications are disease and conditions of the large blood vessels 
and can occur in blood vessels in any part of the body as a result of diabetes. 
 There are 3 main macro vascular complications 
 Cardiovascular disease  
 Cerebrovascular disease 
 Peripheral vascular disease 
 
CARDIOVASCULAR DISEASE 
 People with diabetes are 2-4 times more likely to develop cardiovascular disease 
[CVD] then those without diabetes. However, the risk of coronary artery disease is 
increased in patients with poor glycemic control. Additional mechanisms that contribute 
to the increased risk of CHD and worse outcomes in persons with diabetes include 
endothelial dysfunction, hypercoagulability, impaired fibrinolysis, platelet 
hyperaggregability, oxidative stress, sympathovagal imbalance, and glucose toxicity. 
 
CEREBROVASCULAR DISEASE 
 Cerebrovascular disease term encompassing many disorders that affect the blood 
vessels of the central nervous system. These disorder result from either inadequate blood 
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flow to the brain [i.e, cerebral ischemia] or from hemorrhages into the parenchyma or 
subarachnoid space of the central nervous system [CNS]. Cerebrovascular disease also 
results in strock. Diabetes is an independent risk factor across all ages for stroke. 
 
PERIPHERAL VASCULAR DISEASE   
Peripheral arterial disease [PAD] is an atherosclerotic occlusive disease. It is the 
major risk factor for lower extremity amputations. The risk of development of PAD 
increases threefold in patients with diabetes mellitus24. 
TESTS AND DIAGNOSIS  
GLYCATEDHEAMOGLOBIN (A) TEST [HBAIC] 
 This blood test indicates your average blood sugar level for the past two to three 
months. It measures the percentage of blood sugar attached to hemoglobin, the oxygen-
carrying protein in red blood cells. The higher your sugar levels, the more hemoglobin 
you’ll have with sugar attached. An AIC level of 6.5 percent or higher on two separate 
tests indicates you have diabetes. A results between 5.7 and 6.4 percent is considered 
prediabetes, which indicates a high risk of developing diabetes.. Normal levels are below 
5.7 percent 
Poorly controlled patients = 8-20% 
In non – diabetic patients = 3 – 6.5% 
 
RANDOM BLOOD SUGAR TEST [RBS] 
 A blood sample will be taken at a random time. Blood sugar values are expressed 
in milligrams per deciliter (mg/dL) or mill moles per liter (mmol/L). Regardless of when 
you last ate, a random blood sugar level of 200 mg/dL (11.1 mmol/L) or higher suggests 
diabetes, especially when coupled with any of the signs and symptoms of diabetes, such 
as frequent urination and extreme thirst. A level between 140 mg/dL (7.8 mmol/L) and 
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199 mg/dL (11.0 mmol/L) is considered prediabetes, which puts you at greater risk of 
developing diabetes. A blood sugar level less than 140 mg/dL (7.8 mmol/L) is normal. 
 
FASTING BLOOD SUGAR TEST 
 A blood sample will be taken after an overnight fast. A fasting blood sugar level 
less than 100 mg/dL (5.6 mmol/L) is normal. A fasting blood sugar level from 100 to 125 
mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes. If it’s 126 mg/dL (7 mmol/dL) or 
higher on two separate tests, you have diabetes. 
 
ORAL GLUCOSE TOLERENCE TEST 
 For this test, which is rarely used anymore, you fast overnight, and the fasting 
blood sugar level is measured. Then you drink a sugary liquid, and blood sugar levelsare 
tested periodically for the next two hours. A blood sugar level less than 140 mg/dL (7.8 
mmol/L) is normal. A reading of more than 200 mg/dL (11.1 mmol/L) after two hours 
indicates diabetes. A reading between 140 and 199 mg/dL (7.8 mmol/L and 11.0 
mmol/L) indicatesprediabetes25. 
 
MANAGEMENT OF DIABETES MELLITUS 
 For the management of diabetes mellitus lifestyle modification is necessary along 
with pharmacological treatment 
 
NON PHARMACOLOGICAL TREATMENT 
 Diet Control  :Avoid carbohydrates, sugar, reduction of salt intake Include More 
fiber containing food, vegetables, and fish oils. 
 Moderate Exercise   Include brisk walking, cycling Restrict alcohol consumption 
Avoid stress, avoid smoking 
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PHARMACOLOGICAL TREATMENT 
The treatment option for type 1 diabetes is insulin. Exogenous insulin are Used  
control blood sugar level.  
INSULIN PREPARATION 
Rapid-acting: Onset 5-15 min, Duration 4 hrs. 
 Lispro 
 Aspart 
 
 
Short-acting: Onset 30-60 min, Duration 6-8 hrs. 
 Regular 
 
Intermediate-acting: Onset 1-2 hrs. Duration 10-16 hrs. 
 NPH 
 
Long-acting: Onset 2-4 hrs. Duration 20-24 hrs. 
 Larine 
 Detemir 
 
Pre-mixed:  Onset 30-60 min, Duration 10-16 hrs. 
 30%/70% regular/NPH 
 50%/50% regular/NPH 
ORAL HYPOGLYCEMIC AGENTS 
  
 In type 2 diabetes glycemic control cannot be   achieved be only life style 
modification, along with pharmacological treatment also necessary to control blood sugar 
level. These agents are used as a mono therapy or combination therapy for the treatment 
of type 2 diabetes. 
 
(1)SULPHONYLUREAS 
 
 Sulphonylureas are a class of  oral (tablet) medications control blood sugar levels 
in patients with type 2 diabetes by stimulating the production of insulin in the pancreas 
and inceasing the effectiveness of insulin in he body26. 
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 Example :Glibenelamide, Gliclazide, Glimepiride 
  
 Adverse effects : Hypoglycemia, weight gain 
 
(2)BIGUANIDES 
 
 Biguanides lower blood sugar by:decreasing the amount of sugar producing by the 
liver.increasing the amount of sugar absorbed  by muscle cells.decreasing  the body need 
for insulin27.  
 Examples : Metformin 
   
  Adverse effects:  lactic acidosis, abdominal discomfort, diarrhea, 
Vitamin B12  deficiency. 
 
(3)   A GLUCOSIDASE INHIBITORS 
 
  Alpha –glucosidase inhibitor : A class of oral medications for type 2 
diabetes that decrease the absorption of carbohydrates from  the intestine,resulting in a 
slower and lower rise in blood glucose28. 
   Example :Acarbose, Voglibose, Miglitol 
    
   Adverse  effects : Hypoglycemia , anemia 
 
(4) THIAZOLIDINEDIONES 
 
 These drugs bind to PPAR-y and change insulin dependent gene expression in the 
liver. These drugs increase the effect of insulin in skeletal muscle, adipose and hepatic 
tissues without enhancing pancreatic secretion of insulin29 
   
  Examples : Rosiglitazone, Pioglitazone 
   
  Adverse effects : Water retention , weight gain 
 
(5)MEGLITINIDES 
 
 These drugs bind to ATP sensitive potassium channels and enhance the release of 
insulin from pancreatic cells, it decrease insulin levels and enhance insulin sensitivity in 
cells30 
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 Examples :Rapaglinidde, Nateglinide 
 
 Adverse effects : Weight gain , hypoglycemia 
 
(6)  DIPEPTIDYL  PEPTIDASE FOUR INHIBITORS 
  
 These drugs enhance the effect of GLP-1 and GIP, and increase glucose 
mediated insulin secretion and suppresses glucagon secretion, these drugs mostly 
commonly used as a combination therapy with metformin or TZDs 
 
  Examples :Sitagliptin , Vildagliptin 
  Adverse effects :Upper respiratory infections 
  
 If the glycemic control cannot be controlled by monotherapy, then 
combination therapy is used. If combination therapy is fail to control glucose level, 
and then insulin therapy is started31 . 
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AIM AND OBJECTIVE 
 
AIM 
 The aim of this study is to determine the different prescribe patterns of 
medications prescribed by different endocrinologist in treatment of diabetes type 2 
mellitus patients and to propose possible interventions. 
 
OBJECTIVE 
 
 To study the  prescribing patterns of the drugs used in the management of 
diabetes type 2 mellitus at study site  ,government hospital at tirupur. 
 To obtain the information on demographic characteristic of the patient 
selected for analysis. 
 Collect information on the diagnosis, number of drugs prescribed. 
 Analyze the prescriptions for diagnosis, name,dose and duration of 
prescribed drugs. 
 To assess the diagnosing methods. 
 Observe the entire prescription. 
 To determine attitudes of the physician regarding anti-diabetic drugs 
prescribing pattern. 
 To assess the use of effective anti-diabetic drugs. 
 To establish the most commonly or drug of choice for diabetes type 2 
mellitus patient. 
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PLAN OF WORK 
 
The present dissertation work was planned to conduct a prospective cross sectional 
study to determine prescription patterns of medicine used in treatment of patients with 
type 2 diabetes mellitus. The present study was conducted in government hospital at 
tirupur . Patient diagnosed with type 2 diabetes mellitus with or without co-morbidities 
were enrolled in the study considering the inclusion and exclusion criteria. Informed 
consent was taken from patient at the time of enrolment in to study. 
 
The plan of work includes: 
 
 To get oral or written consent from patient. 
 To design data collection form. 
 Select and identify only outpatient s type 2 diabetes mellitus. 
 To evaluate collected data. 
 Data analysis was done with the help of computer(Microsoft excel 2007). 
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REVIEW OF LITERATURE 
H.B, Matalia,et  al.,(2011). Conducted a study to find out the trend in the 
prescription of antidiabetic medication among in patient with type 2 diabetes. The study 
included 130 patients who had diabetes, of either sex and age. Data was analysed using 
spss 13.0 student’s t-test and analysis of variance (ANOVA) was employed to compare 
quantitative variable and the chi-square test was applied to compare categorical variables. 
The result indicates that 58.46% was male patient out of which 55.26% were having 
history of either smoking or alcohol. The prevalence of diabetes was observed more in 
the population taking non-vegetarian diet. Common disease associated with diabetes 
mellitus was hypertension (45.38%).Highest prevalence of disease was found in the age 
between 51 to 60 years (28.46%). Highest prescribed antidiabetic agent was insulin 
followed by metformin and then glimepiride. In combination. The study indicated that the 
choice of antidiabetic drug remained more or less unchanged compared to previous 
studies. The study also revealed the common use of metformin and glimepiride along 
with insulin treatment for in-patients. The study provides baseline data for carrying out 
further therapeutic audit with more parameter of analysis which in turn will provide 
regular feedback to researchers and prescribers. This will encourage rational prescribing 
in type 2 diabetes mellitus.
32 
 
 Mohammad ShamshirAlam, et al.,(2014). Conducted a study to as certain 
patterns of prescription of oral hypoglycemic agents to type 2 diabetic patients 
compliance. A prospective observational and non-comparative study was conducted in 
200 established diabetes mellitus type 2 patients. Prescription from registered patients 
was also included in the study. Once the consultation by physician was over the 
prescription were reviewed and patient interviewed. The information was collected in 
house designed documentation proforma. In pool of 200 type 2 diabetic more than a half 
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were female(n=106,53%) the mean age of patient was found to be 50.4+11.7 year and 
mean body mass index was 25.8+4.4kg/m2.A total of 432 oral hypoglycemic were 
prescribed. Highly significant Number of patient were prescribed with combination 
therapy.(n=143,71.5%)as compared to monotherapy(n=57,28.5%),p-value 0.0001. 
Biguanides were the most prescribed followed by sulphonylurea, thiazolidinediones and 
alpha glucosidase inhibitor. Good compliance was seen only 77.5% patients. Metformin 
was found to be most prescribed meditation.
33 
 
Bela Patel, et al.,(2013).A  prospective, cross-section study was carried out in 
medicine outpatient clinical of tertiary care hospital, patient with type 2 diabetes and on 
drug therapy for at least one month were included. Patients socio demographic and 
clinical data were noted in pre-designed proforma. Data was analysed by using SPSS 
version 20 and excel 2007. Total number of 114 patient were enrolled with mean (+SD) 
age and duration of 56.8+10.5 and 8.3+9.4 year respectively. Male : Female ratio was 
0.721:1 mean fasting and postprandial blood glucose level were 147.5+73.1 and 
215.6+97.3 mg/dl respectively. Most common symptom was weak/fatigue (77.2%). 
Hypertension (70.2%) was most co-morbid illness. Mean number of drug were 89.5 %  
most commonly used drug group was biguanides (87.7%) followed by sulphonylureas 
(6834%). Metformin was the most utilized (87.7%) antidiabetic drug for type 2 Diabetes. 
This study revealed that the pattern of antidiabetic prescription was rational and largely 
compliant with NICE guidelines.
34 
 
Rajkumar, et al., (2013). In this study 366 prescription slip were randomly 
collected from outpatient diabetic patients for analysis and evaluation. Average number 
of drugs prescribed is 4.98. the most commonly prescribed drugs were oral antidiabetic 
drugs, CVS related (antihypertensive, nitrates, antiplatelet, e.t.c) vitamin and mineral 
insulin, GIT, related drugs, lipid lowering drugs, antimicrobial, CNS related and NSAIDs 
and their percentages were 20.55%, 26.97%, 22.20%, 7.8%, 6.5%,5.75%,2.63% and 
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1.48% respectively. All the drugs were prescribed by non – generic names, which 
included 31.36% drug from essential drug list. Oral forms prescribed were 85.85% and 
injectable were 14.15%(insulin 7.8% and other injectable 6.35%). The average cost of 
oral antidiabetic agent per day prescription was 7.95% and this cost increased to 10.15/- 
with addition of CVS related drugs, 17.23/- with vitamin and minerals and 10.57/- with 
lipid lowering agents and it was seen that if patient prescribed all these drugs then the 
average cost of treatment got raised to 45/-per day per prescription. There is high 
tendency and frequency to prescribe more than two drugs but less used from essential 
drugs prescribed were cardiovascular related drugs and multivitamins along with oral 
antidiabetic drugs. There is an urgent need to develop the prescription writing skills for 
budding doctors regarding the use of essential drugs List to reduce the cost of treatment.
35 
 
Maguire,et al.,(2014). Conducted a retrospective using primary care data. The  
objective of this study was to find out determinants of the initial treatment change 
following initiation on non-insulin antihyperglycaemic treatment (OAD) for UK patients 
with diabetes with type 2 diabetes. Each patient had OAD prescription. The main 
treatment pattern out comes were discontinued switching augmentation and initiation of 
insulin. Glycaemic control was assessed using HbA1c.63060 patient initiated OAD 
therapy 2006-2010 and 3.4% were prescribed insulin during follow-up.26% with at least 
four years of follow-up remained in initial treatment. Metformin dominated 90%. Around 
75% had record HbA1c value >65mmol/mol and one quarter >80mmol/mol. The initial 
value reduced after 12 months and remained stable. There were 15-18% of whose value 
increased since initiating OAD. Increased baseline HbA1c is associated with increase  
chances of augmentation and decrease chance of discontinuation. HbA1c value at one 
year is associated three-fold increase in the chance of  augumentation, 130% increase in 
chance of switching and 14 % increase in chance of discontinuation with each 
10mmol/mol. Following initiation of OAD HbA1c was reduced by an average of 
16mmol/mol in the first year. It was out that there are patient for whom glycaemic control 
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worsens and majority remained above the recommended level suggesting an unmet need 
despite the availability of many OAD.
36 
 
 Richard W.Grant, et al.,(2007). Conducted a study to find prevalence and 
treatment of low HDL cholesterol patient with type 2 diabetes. Patient with type 2 
diabetes remain high risk of cardiovascular event despites. Patient with type 2 diabetes 
remain high risk of cardiovascular event despite aggressive blood pressure,LDL 
cholesterol and blood  glucose control. A total of 7692 patient with type 2 diabetic were 
analysed. He grouped fibrate niacin and n-3 fatty acid preparation as nonstatin HDL 
Cholesterol-raising medicines. It was find out nearly 49.5%  of patient had low HDL 
cholesterol (>40mg/dl for men > 50 mg/dl for women ). Low HDL cholestereol was 
prevalently associated with cardiovascular disease, younger age, and higher A/C level 
nearly  two third of the patient 63.8%  were prescribed a statin. In contrast only 7.9% 
patient were prescribed a nonstation HDL cholesterol – raising medicines. It was find out 
nearly 49.5% of patient had low HDL cholesterol (>40mg/dl for men > 50mg/dl for 
women). Low HDL cholesterol was prevalently associated with cardiovascular diseases, 
younger age, and higher A/C level nearly two third of the patient 6.8% were prescribed a  
statin. In contrast only 7.9% patient were prescribed a nonstatin HDL cholesterol-raising  
medication including 16.4% of patient below the HDL cholesterol goal with CVD Based 
on the studies normalizing low HDL cholesterol in primary care cohort would correspond 
to estimated CVD mortality reduction of 42% in women and 23% in men.Nearly half of 
this patient in this study had low HDL cholesterol level. In contrast to frequent to statin 
use, few patients were prescribed with currently available medicine to raise HDL 
cholesterol level. Low HDL cholesterol represents highly prevalent and potentially 
modifiable risk foe CVD prevention in type 2 diabetes.
37 
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Chung-Yu Huang et al.,(2013). Conducted a study to analyze the utilization 
traditional Chinese medicine (TCM) among type 2 diabetic patient when given as a 
therapy. The use of TCM for type 2 diabetic patient were evaluated using randomly 
sample cohort of 1,000,000 beneficiaries. 77.9%(n+31,289) of type 2 diabetic patient 
utilized TCM and 13.9%(n+, .351) of  them used it for treatment of the disease. Among 
the top ten most frequently prescribed herbal formulae, four remedies, Zhi-bo-Di-Haung-
wan,Qi-Ju-Di-Haung-Wan, Ji Sheng – Shen-Qi-Wan,Ba-Wei-Di-Haung-Wan.Although 
some evidence doesn’t support the use of this herbals the result from the current study 
may have been confounded by placebo effect, which emphasize the need of well 
conducted, double blind,andomized,placebo-controlled studies in order to further 
evaluate the Liu-Wan-Di-Haung-Wan on patient with type 2 diabetes.
38 
  
Roland NneamekaOkoro et al., (2012). Conducted a study to assess the patient’s 
antidiabetic medication adherence levels in non-comorbid diabetes mellitus to identify 
and to evaluate the cause of medication non adherence. Randomly sampled 72 outpatients 
suffering from non-comorbid diabetes mellitus. Patient was interviewed using  self-
administered pre-structured mostly closed ended questionnaires. Adherence was 
measured on a 12-point scale using variation of the Morisky-Green Test;an adherence 
means (+_SD)score of 9.0+_1.0 was recorded. The study participants had a mean(+_SD) 
age of 48.0+_11.7 year majority were females 65.3% and married 77.8%. The adherence 
levels were 1.4%,25%,13.9%and  59.7% for neutral, poor, medium, and good adherence 
respectively. There was a significant association between gender and levels with p>0.01. 
Most common for non-adherence to taking medication as prescribed were feeling better 
(40%), feeling worse due to side effect of anti-daibeticmedication(65%). The nature of 
work and busy work schedule (43%) and long wait time at the clinic (29%) were 
responsible for non adherence to clinic appointments. The majority of participants that 
sometimes missed does of their medication took them as soon they remembered when 
time of the next dose was farand skipped them when the time to the next dose was close. 
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In conclusion, the study revealed a moderate level of good adherence among the 
participants.
39
 
 
 DhwaniKamrai,et al.,(2010) The study was conducted with the objective of 
providing insight in to current use of antidiabetic medication to diabetic and hypertensive 
diabetic and determine how the patient factor influence the prescribing of antidiabetic 
medication. A retrospective epidemiological study was performed using out patient data. 
Data of patient profile form. Data were statistically analysed using SPSS software. A 
total of 492 patients were involved out of which 67.88% were male and 32.11% were 
female. They were further categorized in to age 25.6%belonged to the age group of 65-80 
years. 50% of patient out of 492 studied were suffering from co-existing hypertension. 
Co-existence hypertension was found to be more prevalent in the age group 45-65 
years.59.75% and  its incidence was found to be more in female. Metformin was highly 
prescribed. Metformin and Acarbose were given to obese patient. Sulphonylureas and 
thiazolidinedione were prescribed less. In hypertensive diabetic metformin and 
pioglitazone were mostly prescribed drugs. Monotherapy was  prescribed for 11.3% 
patient  and remaining patient  were prescribed with combination therapy. Biguanides 
and insulin were the mostly prescribed antidiabetics. Since the scope of the study is 
limited to number of patient studies it is less extensive as required to confirm studies are 
required to confirm the findings.
40 
 
 ManjiriPawaskar, et al., (2013). Conducted study to evaluate medication 
utilization in patient with type 2 diabetes mellitus treated with exenatide BID (exenatide) 
versus insulin glargine (glargine). In the study adult patient(>_ 8 years of age) with type 2 
diabetes who were initiator of excenatide or glargine were selected. To control for 
selection bais, propensity score matching was used to complete a 1:1 match of glargine to 
exenatide patients. A total of 9,197 exenatide and 4,499 glargine treated were selected. 
Propensity score matching resulted in 3,774 match pairs with mean age of 57 and mean 
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age DeyoCharlson comorbidity index score of 1.6;54% patient were male. The treatment 
intensification rates were 15.9% and 26.0% (p<0.0001) and discontinuation rate were 
38.3% and 40% (p=0.14) for exenatideandglargine respectively. Alternatively 14.9% of 
exenatide treated patients switched their therapies compared to 10% glargine treated 
patients (p>0.0001). Overall, glargine treated patient were likely to modify their 
treatment with shorter mean time on treatment until modification. Compared to exenatide 
treated patients, glargine treated patient were likely to discontinue or intensify therapy. 
But likely to switch the index therapy. Patient treated for type 2 diabetes with exenatide 
BID or insulin glargine differ in adherence to therapy.
41 
 
 Ibrahim  A.Ibrahim, et al.,(2008). Conducted  the study to examine the drug 
regimens diabetic patient receiving home health care service to measure the prevalence of 
polypharmacy and to asses likelihood of drug- drug interaction and the consequence. The 
study consisted 139 patients. Information regarding medication was collected by home 
health nurse during the initial home visit and was recorded in patient medication sheet. 
Any change in medication was noted. All systemic medication prescribed were identified. 
Micromedexo formulary DRUG-REAX SYSTEM was used to identify drug- drug 
interaction. It was found that average number of medication taken was 8.9(SD 3.4) 
prescribed medication per day. The show that 38.8% of patients in the sample could 
potentially subjected to at least one severe drug- drug interaction. Nearly all the patient 
(92.8%) were at risk of moderate drug- drug interaction, and 70.5% would have mild 
drug- drug interaction. It was concluded that polypharmacy is concern for home health 
care patients with diabetes and potential drug-drug interaction is substantial. Result 
indicates to avoid adverse events such hospitalization.
42 
 
 YahayaHassan,et al.,(2009). Conducted a study to identify trend of in utilization 
of oral hypoglycemic agent (OHA) in effort to expand the exisiting knowledge and to 
describe changes observed. Prescription records were retrospectively reviewed in the 
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outpatient department. About 12,000 prescriptions containing at least one OHA were 
systematically sampled and evaluated. Chinese Patients had decreasing trend in OHA 
with decreasing trend usage over time (52.2% to 48.5%). In contrast metformin 
Biguanides agents, recorded an increase in utilization over the study period, Suggesting a 
new trend for prescribing practices among medicalpractitioner (48.6% to 51.3%;p-
value<0.001). Although monotherapy was popular with metformin overall pattern 
profound favoured combination therapy. This study also found an increasing pattern in 
the use OHA with insulin rather than triple OHA therapy among practitioners. The 
Biguanides is gradually becoming a new reigning lord of OHA replacing sulphonylureas. 
Pattern of OHA use is shifting towards combination therapy mainly dual OHA therapy 
and OHA-insulin therapy.
43 
 
 Mohammad Yasmeen Abbasid, et al., (2014). Conducted a prospective 
observational study for a period of six month in Inpatient department. Patient of either 
sex age >_ 8 years and above, patients who were diagnosed as diabetic were included in 
the study. A total of 133 patients were recruited for study,61% of the patients were male, 
and 39% were female. Most of the patients were age group 51-65(44.36%).70.67% had 
no family history of diabetes,59.33% of patient had family history. The major co-
morbidities was hypertension (43.64%) followed by hyperlipidaemia (17.67%). The total 
prescribed antidiabetic medication was 31.58%. Among the antidiabetic drug given 
Metformin was the most  prescribed 35.26% followed by sulphonylureas 30.65% then 
insulin 21.96% thiazolidiones 9.12%, and DPP-4 Inhibitor 1.65%. It was find out 
prescribing pattern of drug should be based on the severity of disease 
condition,Associated comorbid and currently available evidence in order to promote 
quality use of drugs.
44 
 
 HarikrishnanK.V,et al.,(2012)Conducted observational prospective study to find 
prescription pattern and insulin treatment in diabetic patients. The study also included the 
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patient analysis of patient information and comorbid condition. The objective was to 
determine the Patient information, prescription pattern and treatment of type  DM using 
insulin. Patient information such as MRD no, sex,age, duration of hospital stay, comorbid  
condition,patient profile information and details of insulin treatment were collected. In 
total 50 patients were used, 72% were male and 28% were female. From the medication 
profile of the patient it was found that 43 patient are treated with insulin. It is observed 
from  the study insulin is commonly used in all type 2 diabetes mellitus patient. Human 
mixtard and human atrapid are two common classes of insulin which is used for 
treatment.
45 
 
  K  U  Denish,et al.,(2007).Conducted a prospective study to identify and analyze 
pattern of potential DDIs (drug-drug interaction) in diabetes patient. A total of 182 
patients were prescribed 685 drugs were enrolled. Patient 51 to 60 age had higher risk 
developing DDls. It was found that of DDIs 49.5%. The common potential DDIs 
observed was between metformin and enalapril.
46 
 
 BalazsHanko,et al., (2002). Conducted a study to evaluate the utilization of 
antidiabetic drugs. The consumption of antidiabetic drugs was analyzed by the 
ATC/Defined Daily dose (DDD) method. The total consumption of antidiabetics 
increased by 41.8%, and reached 47.59 DDD/1000 inhabitant/day. The consumption of 
oral antidiabetic increased by 33.41% (DDD/1000 inhabitant/day) while in the case 
insulin was 67.8% (13.74 DDD/1000 inhabitant/day) sulphonylureas were most 
frequently used class. Glibenclamide was the most frequently used antidiabetic drug. The 
insulin class had greater emphasis in therapy. Among oral antidiabetic, the consumption 
rate of sulphonylureas decreased and the consumption rate of biguanids and acarbose 
increased.
47 
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 VitthalKuchake, et al., (2010). Conducted a  study to evaluate the prescribing 
pattern of antidiabetic and compare serum lipid profile in diabetic patient. 163 patient 
were enrolled in the study. Fasting serum lipid profile was analyzed. Antidiabetic 
medication were evaluated in selected the study population for prescribing pattern of drug 
and their cost evaluation. Among various antidiabetics, Biguanides were mostly 
prescribed. Most the study subjects had lipid abnormalities and there was statistically 
difference in the proportional of subject with different BMI category and lipid 
abnormalities. Significant increase in level serum cholesterol (p<0.01) and serum LDL-C 
(p<0.0001) and significant decrease HDL-C (p<0.0001) in over weight subject was 
observed. Metformin was the commonly prescribed. Elevated LDL-C and serum 
cholesterol and reduce HDL-C are prevalent lipid abnormalitiles in diabetic mellitus 
patient.
48 
 
Giorgio L Colomb,et al., (2012).Conducted the study to evaluate the use of 
antidiabetic with particular reference to type of treatment. The analysis was carried out on 
sample of 169,375 patient treated with oral blood glucose lowering drugs. Patients were 
considered on treatment with oral blood glucose lowering-drugs if they received at least 
one prescription of antidiabetic drug. The mean annual number of hospitalizations was 
lower in the dual therapy group; average number of specialist examination was lower in 
fixed-combination group. Patient on monotherapy showed a better percentage for 
glimepiride (70.5%) and pioglitazone(70.4%), whereas the adherence in fixed-
combination therapy was recorded for metformin+pioglitazone(75.5%). The average 
annual cost per diabetic patient was $2388, with difference between the monotherapy 
$2321, fixed-combination $2270 and dual therapy $2465 groups. Fixed combination 
therapy involved a lower mean expenditure for insulin, other drug, and specialist and 
diagnostic care. Thiazolodinediones showed the lowest average annual cost per patient 
among the monotherapies, with a marked decrease in cost for hospitalization, specialist 
care, and diagnostic.
49 
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 PL De pablos-Velasco, et al., (2005). Conducted a study find out the pattern of 
hypoglycemic treatment and to estimate the prevalence of known and drug treated 
diabetes mellitus. A total of 2924 diabetic patient >20 years old were selected. Of the 
DM-2 patient 4.4% received diet only, oral drugs, insulin or combination. The duration of 
DM-2 was associated with more oral drug and more insulin treatment, but duration of 
DM-1 was not associated with intensive insulin therapy; >50% of type 1 patient has 
>3daily injections. The prescribtion of Biguanides were scarce, 1/3 of them were 
buformin. DM-1 and DM-2 patients were treated with similar does of insulin, but DM-1 
and DM-2 patients were treated with similar does of insulin, but Dm-1 patient had more 
insulin injection (2.56 vs 2.07, p<0.001). The estimate prevalence of known and drug 
treated diabetes were 5.95% and 5.73%. The prevalence of known and drug treated 
diabetes is among the highest reported in European population. The prescription of 
metformin and combination therapy in DM-2 and of intensive insulin therapy in DM-1 is 
more intensive and uses more fast-acting insulin than DM-2.
50 
 
 SudhaVengurlekar,et al., (2008).  Conducted a study to access prescribing 
practice and general trend of diabetes among patient. The study revealed that metformin 
(27%) and glimepiride (22.03) were found maximum among various antidiabetic drug. 
Category wise the maximum prescribed drugs were glimepiride (22.06%), 
sulphonylureas metformin (27%,biguannide) and pioglitazone (13.90%, glitazone). 
Insulin prescription was found to be less (4.5%). Combination of metformin and 
glimepiride was found to be 20.86% which was prescribed more. Most prevalence of 
disease was found to be in the age group of 51-60 year old followed by age group of 41 
to 50 male patient (66.36%) were found predominant over female(33.64%) patient.
51  
 
 Dolores Mino-Leno,et al.,(2005).Conducted study to describe the treatment and 
outcome in terms of degree of metabolic control in patient, asses the agreement between 
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the doses of antidiabetic drug by the patient and those written in the medical records, and 
describe the drug utilization characterization in relation to the standard of care. 
Consecutive patient with type 2 diabetes were interviewed regarding lifestyle, diet, 
glycosylated haemoglobin level, and treatment. Concordance between information 
obtained through medical records and patient interviews was analyzed. Metabolic control 
was deficient in 40%, acceptable 28%, good in 32% of 181 patients with available 
information. For 19% patient there was disagreement between the doses of antidiabetic 
drug reported. For 41% patients, treatment in the medical history was in agreement with 
published standards. Identification of disagreement between standard of care and clinical 
identification and clinical practice in type 2 diabetes management is the basis to improve 
drug utilization and achieve better metabolic control in patient.
52 
 
 Fredric J.Cohen, et al.,(2003).Conducted study to determine whether 
antihyperglycemic agent prescribing pattern has changed currently with introduction of 
new drug, and whether those changes were related to changes in the underlying patient 
population. A sample of patient with suspected type 2 diabetes was identified. Patient 
with type 2 diabetes were identified among those continuously enrolled in the database 
for one year. Drug therapy episode were identified were defined by sequential fulfilment 
of prescription implying a continuous supply of particular drug (or combination) of at 
least 30 days duration.Univerariate analyses were used to explore trend over time in drug 
prescription and patient  characteristic. Multivariate logistic regressions were used to 
isolate the impact of year from other variable on the like hood of receiving prescription 
for a specific therapy. A total of 232,020 unique diabetic patients had an average of 1.91 
diabetes therapy episodes. Monotheraphy with sulphonylureas decreased but 
monotherapy with thiazolidinedione,metformin and other antidiabetic drugs increased 
over time. Combination of sulphonylureasandmetformin,sulfonylureas and 
thiazolidinedione, metformin and thiazolidinedione;and sulfonylureas, metformin 
,thiazolidinedione increased with time interval. Insulin monotherapy decreased as did 
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insulin combination therapy with sulfonylureas. The combination of insulin and 
metformin combination therapy increased, whereas insulin and thiazolidinedione was 
stable. The influence of year on prescribing patterns remained highly significant 
(p>0.001) after adjusting for patient characteristics. Antihyperglycemic prescription 
pattern have changed in recent years in parallel with. And probably as direct a result of 
introduction of different classes of medication. Overall, The prescribing trend has been 
away from monotherapy with insulin and sulfonylureas and towards combination 
therapies, presumably in attempt to reduce hypoglycemic symptoms and achieve better 
glucose control.
53 
 Kristian B.Filion, et al.,(2009).Conducted a study to describe trend of 
prescription of antidiabetic medication among type 2 diabetic patient. Using data from 
general practice Research database they constructed a cohort of patient with type 2 
diabetes. Daibetes was defined as the presence of diagnosis of diabetes, HbA1c>_%, and 
or >_% prescription for antidiabetic medication. Analyses were conducted for the full of 
cohort as well as sub-cohort with incident of diabetes. The cohortstudy included 67981 
patients and a total of 320,089 patient-years and the sub cohort had 30,324 patients with 
incident of diabetes and 111,890 patient-years. From 2000-2006 year there was 
substantial increase in the prescription rate of antidiabetic medication. The greatest 
relative increase occurred in the prescription of thiazolidinediones. The greatest absolute 
increase occurred in the prescription of  metformin which surpassed sulfonylureas which 
was the most prescribed antidiabetic medication among patient with type 2 diabetes 2002. 
Among those with incident diabetes, overall prescription rate were 4.6% prescription/ 
patient-year  2002 and 13.6 prescription/patient-year 2006. It was found that there was 
substantial increase between 2002 and 2006 in the UK in the prescription of antidiabetic 
medication. This increasingly affressive pharmacology management is consistent with 
recent practice guidelines.
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PremlataDas,et al.,(2009) Conducted an observational follow up in 154 newly 
diagnosed diabetes mellitus patient. The aim of the study was to determine the 
demographic, prescribing pattern, drug cost and analysis effectiveness of different 
therapies. Effectiveness of therapies was analysed in patient achieving glycemic control 
by Wilcoxon signed rank test. Majority of the patients(n=114) fell in to middle age strata 
of 35-64 years and 97% were type 2 diabeties. A total of 282 prescriptions were screened 
that included antidiabetic drugs and drug categories. Mean number of drugs per 
prescription sheet was 1.83+-1.33. Oral hypoglycemic are advised to 64% patients. The 
prescribing frequency of biguanides was (24./5%) was more than sulphonylureas 
(19.9%). Only 67 of the patient followed up to 3 months +_13 days, of which 46 
achieved glycemic control. The biguanindesonly(n=0.002) and combination therapy of 
biguanides and sulphonylureas group (p=0.005) highly effective therapies, as their p 
value of fasting blood levels follow up were the lowest. Nearly 90% of combination 
therapy achieved glycemic control. In conclusion, this study reflects the therapeutic 
approach followed in diabetes mellitus as optimal. Future  research on a larger patient is 
warranted to evaluate existing pattern of therapy for sound practice and quality of care.
55 
 V.Sivasankari,et al., (2013). Conducted study to evaluate utilization pattern of 
antidiabetic drug in type 2  diabetic DM oatient. A prospective observational study was 
carried ot for a period of 6 months. Out of 1456 patient screened, 92 types 2 diabetes 
were included and structured questionnaire was used to collect data analysis done. The 
prevalence was about 6.3% and 68.47% of them were 40 to 60 years of age. Hypertension 
was common co-morbid condition |(19.6%) followed by hypercholestremia (3.3%). 
Totally 21.74% of the patient was on monotherapy and metformin was commonly 
prescribed. In combination therapy, glibenclamide and metformin (35.86%), followed by  
glimepiride and metformin (9.78%) and injection insulin mixed with metformin 
(27.17%). Statin was co-administered in 5.5% of patient and there was no evidence of 
polypharmacy. It was concluded type 2 DM was treated effectively with both insulin and 
oral hypoglycemic drugs Glimepiride can be substituted by glibenclamide due to better 
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pharmacological and pharmacokinetic properties. Statins and low ACE inhibitor can 
added according to recent ADA guidelines to minimize the complication of DM.
56 
  
ShruthiVihangBrahmbhatt, et al(2014). Conducted  a prospective non 
interventional study aimed to gather and study the drug utilization pattern in diabetic 
patients. 50 diabetic patients were involved. Patient were included in the study after 
obtaining written informed consent from, all relevant data was collected from case 
records froms and analysed. Diabetes mellitus was high in patient with age group 60-70 
years, affecting 66% male and 34% female. It was found out metformin is the most used 
drug with least adverse effects and insulin was used to treat uncontrolled state, where 
physician have considered the socio-economic status while prescribing which is obvious 
least use of costly insulin preparation.
57 
 
 Shaktibala Dutta, et al., (2014).  Conducted the study to design and analyse 
current prescriptionmpatterns for drugs used in the treatment of type 2 diabetic mellitus 
patient. Prescription  were randomly evaluated for prescribing pattern using WHO 
indicators. At total of 312 of prescription were anlysed. Mean age was 54.94+_0.57 
years. Male to Female ratio is 1.04:1,socio economic status : upper 24 (7.69%), upper 
middle 75(240.4%), lower middle 93(29.81%), upper lowr 69(22.11%) and lower 
51(16.35%). Family history of diabetes mellitus seen in 129 (41.35%) patient and 
average duration was 7.92+_0.37 years. A total of antiplatelet 42(3.38%) statin and 
360(5.56%) miscellaneous category were prescribed. Amongst antidiabetics, the most 
frequently prescribed drugs were metformin 273 (40.99%)glimepriride 228(34.23%) then 
pioglitazone 45(6.67%), acarbose 33(4.95%), gliclazide 30(4.5%), sitaglipitin 
30(4.5%),glibenclamide 15(2.25%) and insulin 12(1.8%). 99.03% oral drugs were 
prescribed. Number of fixed dose combinations were of antidiabetic drugs were 
prescribed. Number of fixed dose combinations were of antidiabetic drugs were 
246(36.93%).3.39% drugs per prescription were we prescribed.288(43.24%) antidiabetic 
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drugs were prescribedfrom national list of essential medicines (NLEM),20.11.100%were 
prescribed by brand names. The most prescribed drugs were metformin glimepiride. 
Rational prescribing can be improved by sensitizing our physicians and providing them 
with feedback of study.
58 
  
Camilo Molino Guidoni, et al.,(2012). Conducted a study to analyse drug 
prescriptions for insulin and oral antidiabetic drug in type 1 and type 2 diabetes mellitus 
patient. All patients with diabetes were included in the study. Total of 3982 patient were 
included. Mean age was 60.6 years and 61% were female. 60% were treated with 
monotherapy than in polytherapy. Ten patient received doses of glibenclamide or 
metformin above the recommended maximum doses, and in elderly patient there was no 
reduction in drug doses. It was out that monotherapy with oral antidiabetic drugs was 
predominant procedure and the doses were not individualized according to age.
59 
  
AbdulGafar O. Jimoh, et al.,(2011). Conducted descriptive cross-section study 
to find out pattern in which drugs are prescribed among diabetic type 2 patients. The 
study included 496 patient case notes with mean age 46.5+_12.5 years. Male to female 
ratio was 1:1.5.Majority patient were type 2 diabetic (90.3%). The percentage of patient 
on antidiabetic monotherapy and combination therapy were 28.8 and 75.2 respectively. 
Of 348 patient on antidiabetic combination therapy 293(84.22%) and 55(15.8%) were 2 
and 3 drug respectively. Overall metformin was the most prescribed 81.9%. However as  
monotherapy metformin was overtaken by insulin as most frequently utilized. 
Hypertension was the most frequent comorbid condition (43.9%) observed in the study 
and antihypertensive agents particularly angiotensin converting enzyme in hibitor 
(ACEI)/angiotensin receptor blocker (ARB) monotherapy. The study revealed that the 
pattern of antidiabetic prescription was rational and lagely complaint with clinical 
guidelines. However, antihypertensive agents was found underutilized for managing 
patients with both hypertension and diabetes.
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PATIENT & METHODOLOGY 
 
NAME OF THE STUDY 
Prescription  pattern of medication given in the management of type 2 diabetic 
mellitus in outpatient department. 
 
STUDY DESIGN 
 A prospective cross sectional study was performed on 110 patients to know the 
prescribing patterns of medication used in the treatment of type diabetes mellitus, for six 
months between July 2017 and March 2018. 
 
STUDY SITE 
 This study was conducted in the outpatient diabetology department. 
 
DURATION OF STUDY  
 
    The study was conducted for six months. 
 
STUDY POPULATION  
 
 Patient who visited the diabetic department in government hospital at tirupur  were 
included in this study. 
 
SAMPLE SIZE 
 A  total of 110 patients were enrolled in the study. The patients who had type 2 
diabetes mellitus were included in this study. 
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STUDY CRITERIA 
 
Inclusion Criteria  
 Only prescriptions of patients who are diagnosed to have diabetes type 2 
mellitus. 
 Diabetes type 2 mellitus patients with either sex. 
 Patients who were willing to participate in the study. 
 Patients diagnosed with type 2 diabetes mellitus. 
 Out-patient for type 2 diabetes mellitus. 
 
Exclusion Criteria 
 
  Patients who are not willing to participate in the study. 
 In-patients. 
 Patient who visited for other purpose like renal disease or  renal 
dysfunction with congestive heart failure. 
 L
a
c 
 

OBSERVATION AND RESULTS  
_____________________________________________________________________________ 
 
__________________________________________________________________        
The Erode college of Pharmacy                                                                 37 
 
 
OBSERVATION AND RESULTS 
Table 1 : Showing Gender Wise Distribution In Type 2 Diabetes Patient 
Sex No of Patient Percentage% 
Male 52 47.27% 
Female 58 52.73% 
Total 110 100 
 
47.27 men and 52.73% women taken for this study. 
 
GENDER WISE DISTRIBUTION 
 
 
Figure 1: Showing percentage of gender wise distribution in type 2 diabetic 
mellitus. 
 
Out of 110patient 52(47.27%) patient were male and 58(52.73%) were female. 
According to this male were prevalent to diabetic type 2 mellitus than female patient. 
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Table 2 : Showing age wise distribution in type 2 diabetes mellitus. 
Age Group No of patient Percentage 
Up to 40 Years 8 7.27% 
41-50 years 22 20% 
51-60 years 19 17.27% 
61-70 years 41 37.27% 
71 and above 20 18% 
Total 110 100 
 
Type 2 diabetic mellitus was more prevalent in age group between 61-70 
                                                 [41(37.27%)] years 
 
AGE WISE DISTRIBUTION 
 
 
 
In this study the revealed that type 2 diabetic mellitus patient was more 
prevalent in the age group 61-70 years [41(37.27%)] followed by the age group of 
51-60 year [19(17.27%)]. 
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Table 3: Illustrating Details of Drugs prescribed For Patient with Type 2  
                                        Diabetic Mellitus 
Drug Name No of prescription Frequency (%) 
Biguanides 77 70% 
Sulphonylureas 64 58.18% 
Insulin 32 29.09% 
Antiplatelet 10 9.09 
Angiotensin receptor blockers 26 20% 
Beta-blockers 22 15.71% 
Calcium Channel blockers 16 14.54% 
Nitrates 7 6.37% 
Diuretics 15 13.63% 
ACE inhibitor 20 18.18% 
Alpha adregenic 6 5.45% 
Proton pump inhibitors 25 22.72% 
Antiemetic 10 9.09% 
Anti-drepresant,anxiolytic 15 13.63% 
Antipyretic, analgesic 22 20% 
Calcium, Folic acid, Iron 12 10.90% 
Antibiotic 27 24.54% 
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DETAILS OF DRUG PRESCRIBED 
 
 
 
Figure 3 : Illustrates prescribing pattern of drugs in this study population. 
 
 Mostly commonly prescribed anti-diabetic drug was Biguanide 70% 
followed by sulphonylureas 64%., followed by angiotensin receptor   blockers 20% 
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Table 4 : Monotherapy And Combination Therapy of Antidiabetic Drugs 
Prescribed In Type-2 Diabetic Patient 
Drugs No of Patient  Frequency (%) 
Monotheraphy 78 70.43% 
 
 78(70.43%) type-2 diabetic patient received monotherapy. 
 
 
 
 
Figure 4: Showing different approach of treatment of type 2 diabetic patient 
 
 
 The study revealed that 70.43% patient were prescribed with monotherapy drug. 
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Table 5 : Distribution of classes of Anti-Diabetic Drugs Prescribed In Type -2 
Diabetic Patient As Monotherapy  and Combination Therapy 
 
Drug Groups Monotherapyn(%) 
Biguanides 77(70%) 
Sulphonylureas 64(58.14%) 
 
Biguanides (metformin) was highly prescribed as monotherapy in (70%) patient  
 
 
 
Figure 5 : Distribution of classes of anti-diabetic drugs prescribed in type -2 diabetic 
patients as monotherapy and combination therapy. 
 
 The study revealed that Biguanides was highly distributed as monotherapy (70%) . 
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Table 6: Who Core drug Prescribing Indicators 
Parameter Value 
Average  number of drugs per prescription 5.45 
Percentage of drugs prescribed by generic name Nil 
Percentage of encounter with an antibiotic 
prescribed 
3.03% 
Percentage of encounters with an injection 
prescribed 
5.05% 
Percentage of drugs prescribed from essential 
drug list 
40.23% 
 
Average number of drugs prescribed per prescription was 5.45 
 
 
Figure 7 : WHO core drug prescribing indicators 
 
 The study revealed that there was no drug prescribed with its generic name, 
percentage of encounter with antibiotic is 3.03%, the average number of drugs per 
prescription is 5.45, percentage encounters with an injection was 5.05% and percentage 
of drugs prescribed from essential drugs list is 40.23%. 
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Approach of Treatment 
 
 According to this study more number of patient received monotherapy treatment 
[78(70.43) .As shown in table 4. 
 
 In monotherphy the result showed that Biguanide  (metformin) [77 (70)]] and 
Sulphonylureas (Glimepride)[64(58.41)] were the least prescribed anti-diabetic 
drugs. As shown in table 5. 
 
 
 In  momotherapy, Biguanides was highest prescribed, 77[(70)], followed by 
Sulphonylureas[64(58.14)]. 
 
 32(29.09%) of the patient were prescribed with insulin injection. As shown in 
table 3. 
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Table 2 : Showing age wise distribution in type 2 diabetes mellitus. 
Age Group No of patient Percentage 
Up to 40 Years 8 7.27% 
41-50 years 22 20% 
51-60 years 19 17.27% 
61-70 years 41 37.27% 
71 and above 20 18% 
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Type 2 diabetic mellitus was more prevalent in age group between 61-70 
                                                 [41(37.27%)] years 
 
AGE WISE DISTRIBUTION 
 
 
 
In this study the revealed that type 2 diabetic mellitus patient was more 
prevalent in the age group 61-70 years [41(37.27%)] followed by the age group of 
51-60 year [19(17.27%)]. 
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Table 3: Illustrating Details of Drugs prescribed For Patient with Type 2  
                                        Diabetic Mellitus 
Drug Name No of prescription Frequency (%) 
Biguanides 77 70% 
Sulphonylureas 64 58.18% 
Insulin 32 29.09% 
Antiplatelet 10 9.09 
Angiotensin receptor blockers 26 20% 
Beta-blockers 22 15.71% 
Calcium Channel blockers 16 14.54% 
Nitrates 7 6.37% 
Diuretics 15 13.63% 
ACE inhibitor 20 18.18% 
Alpha adregenic 6 5.45% 
Proton pump inhibitors 25 22.72% 
Antiemetic 10 9.09% 
Anti-drepresant,anxiolytic 15 13.63% 
Antipyretic, analgesic 22 20% 
Calcium, Folic acid, Iron 12 10.90% 
Antibiotic 27 24.54% 
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Figure 3 : Illustrates prescribing pattern of drugs in this study population. 
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Table 4 : Monotherapy And Combination Therapy of Antidiabetic Drugs 
Prescribed In Type-2 Diabetic Patient 
Drugs No of Patient  Frequency (%) 
Monotheraphy 78 70.43% 
 
 78(70.43%) type-2 diabetic patient received monotherapy. 
 
 
 
 
Figure 4: Showing different approach of treatment of type 2 diabetic patient 
 
 
 The study revealed that 70.43% patient were prescribed with monotherapy drug. 
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Table 5 : Distribution of classes of Anti-Diabetic Drugs Prescribed In Type -2 
Diabetic Patient As Monotherapy  and Combination Therapy 
 
Drug Groups Monotherapyn(%) 
Biguanides 77(70%) 
Sulphonylureas 64(58.14%) 
 
Biguanides (metformin) was highly prescribed as monotherapy in (70%) patient  
 
 
 
Figure 5 : Distribution of classes of anti-diabetic drugs prescribed in type -2 diabetic 
patients as monotherapy and combination therapy. 
 
 The study revealed that Biguanides was highly distributed as monotherapy (70%) . 
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Average  number of drugs per prescription 5.45 
Percentage of drugs prescribed by generic name Nil 
Percentage of encounter with an antibiotic 
prescribed 
3.03% 
Percentage of encounters with an injection 
prescribed 
5.05% 
Percentage of drugs prescribed from essential 
drug list 
40.23% 
 
Average number of drugs prescribed per prescription was 5.45 
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Approach of Treatment 
 
 According to this study more number of patient received monotherapy treatment 
[78(70.43) .As shown in table 4. 
 
 In monotherphy the result showed that Biguanide  (metformin) [77 (70)]] and 
Sulphonylureas (Glimepride)[64(58.41)] were the least prescribed anti-diabetic 
drugs. As shown in table 5. 
 
 
 In  momotherapy, Biguanides was highest prescribed, 77[(70)], followed by 
Sulphonylureas[64(58.14)]. 
 
 32(29.09%) of the patient were prescribed with insulin injection. As shown in 
table 3. 
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DISCUSSION 
Diabetes mellitus is a major public health problem worldwide. Its prevalence is 
rising in may parts of the developing world, India is no exception, currently India is 
facing a three – fold rise in the prevalence of diabetes, and it will become diabetes capital 
of the world in near future. Individuals with type-2 diabetes are considered on high 
priority as they are potential candidates for rapid evaluation to prevent and halt the 
progession of complication.
54 
In this study we found out patient of age group 61-70 years were most affected by 
type-2 diabetic mellitus disease, similar to that obtained in other studies. In this study 110 
out-patient were enrolled, out which 52(47.27%) were male patients and 58(52.73%) 
were female patients. Therefore high proportion of diabetic patients in this study were 
represented by male similar to the other findings and in contrast to other studies.
40, 
It was observed some of the 110 enrolled out-patient were suffering from co-
morbidity disease such as Hypertension, Hyperlipidaemia, Diabetic retinopathy, Diabetic 
nephropathy that’s why cardiovascular drug were together prescribed along with anti-
diabetic drugs. Therefore the average no of drugs prescribed to these outpatients was high 
due to co-morbid illness of patient in this study, and they required more medication for 
the additional illness. Different studies also reported the same observation with regard to 
the co-morbidity in patients with diabetes.
58 
It was found that average number of drugs per prescription was 5.45 which were 
almost similar to finding of Raj Kumar et al, 2013 and in contrast in other lisha jenny 
Johny et al, study in which 3.2+1.3 drugs were prescribed per prescription. The trend in 
this study showed that previous studies had positively influenced the diagnostic skills and 
the prescribing habits of doctors, though there is need for improvement.
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Biguanides (Metformin), Sulphonylureas and Alpha-glucosidase inhibitor were the 
most prescribed anti-diabetic drugs where in sulphonylureas were most prescribed anti-
diabetic drugs. Among the second generation sulphonylureas, glimepiride was the most 
commonly prescribed along with metformin which is in accordance with studies from 
H.B.Matalia et al,2011 Shaktibala Dutta, et al,2014
58
. 
The most commonly co-prescribed meditation along with anti-diabetic drugs were 
hypolipidemicagents(Statin),followed by Angiotensin receptor blockers then antiplatelet 
drugs which was as same as Abdul GafarO.Jimoh et al,2011 in which antihypertensive 
were most commonly co-prescribed medications.
60 
A few percentages of patients were given injection due the fact only type-2 
diabetic patient were taken for the study of which they utilized mainly oral 
hypoglycaemic agents only. The most prescribed injection was insulin which is given in 
circumstances where hyperglycemia is not controlled by diet and exercise or when oral 
hypoglycemic agents fail to surpass the rise of blood sugar. Our study is contrast to 
H.B.matalia, et al study whereby insulin was highly prescribed followed by metformin 
and then glimepride.
60 
In this study the drugs were written with trade (non-generic) names, while none of 
the drugs was mentioned with their generic name, and drug from essential drug list were 
40.23%. this further emphasizes the need to reduce the cost of medications to patients 
through increased prescription of their generic names and reduction in number of drugs 
per prescription to foster patients compliance and rational drug prescription without a fall 
in treatment standard towards attaining optimal diabetic control. Prescribing by generic 
name allow flexibility of stocking and dispensing various brand of a particular drug that 
are cheaper than and as effective as proprietary brands. 
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SUMMARY 
 
 A total of 110 patients who fulfilled both the inclusion and exclusion. 
 
 The study revealed that type-2 diabetic mellitus affected male patients to a 
larger extend compared to the female patient. As shown in Table 1. 
 
 
 Monotherapy was more utilized compared to other combination therapy. As 
shown in Table 5. 
 
 Type-2 diabetic mellitus affected mostly elder people of age group 61-70. 
As shown in table 2. 
 
 
 This study found out the Biguanides were commonly prescribed followed 
by Sulfonylurea. As shown in Table 5. 
 
 It was found that some of type-2 diabetes mellitus patients had co-morbid 
diseases. 
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CONCLUSION 
To conclude this, most of the prescription was rational, though further 
improvement is needed. 
The study indicated that the choice of anti-diabetic remained more less the same 
compared to previous studies. Type-2 diabetes mellitus is most common in elderly patient 
since the diseases was more predominant in age group of 61-70. 
The study revealed metformin was most utilizes anti-diabetic drug for type-2 
diabetic patient.Most of diabetic patients have co-morbid conditions; therefore they 
require more than one medication for their proper was compliant with NICE (National for 
Health and Clinical Excellence) guidelines hence it was ration. 
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PROFORMA 
 
Name:    IP.NO:   AGE: 
SEX:    WEIGHT: 
 
CHIEF COMPLAINTS: 
 
PAST MEDICAL HISTROY : 
 
PHYSICAL EXAMINATION: 
 TEMP : 
 PULSE : 
 BP: 
 RR: 
 
LABORATORY TEST: 
Test Date 
     
EPG      
BMI      
PPG      
HbA1C(%)      
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PAST MEDICATION HISTROYDRUG CHAT: 
 
T.NAME G.NAME DOSE FRWQ DATE 
            
                
                
                
                
                
                
                
                
                
                
 
 
SIGN: 
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PATIENT WRITTEN INFORMED CONSENT 
 
I understand that my participation in voluntary and that I may withdraw from this 
study at any time without giving any reason or to answer any particular questions in the 
study. I consent the member of the study to have access to my response and public the 
result provided my identified is not revealed. I voluntary agree to participate in the study 
 
 
 
Name and signature of the patient 
 
 
 
 
 
Date : 
 
 
 
